Federal Ministry of Defence

Abstract The article contains sections titled: 1. Introduction 2. Cadmium Metal 2.1. Physical Properties 2.2. Chemical Properties 2.3. Occurrence, Raw Materials 2.4. Refining 2.4.1. The Starting Materials 2.4.2. Leaching of the Starting Materials and Cementation 2.4.3. Electrolytic Recovery 2.4.4. Distillation 2.4.5. Other Processes 2.4.6. Recycling 2.5. Quality Specifications and Analysis 2.6. Uses 3. Alloys 4. Cadmium Compounds and Complexes 4.1. Properties 4.2. Individual Compounds 4.3. Storage and Transportation 5. Environmental Protection 5.1. Emission 5.2. Waste Water 5.3. Air 5.4. Soil 6. Economic Aspects 7. Toxicology and Occupational Health

Previous work has shown that fibroblast-derived collagenase/matrix-metalloproteinase-1 (MMP-1), responsible for the breakdown of dermal interstitial collagen, was dose-dependently induced in vitro and in vivo by UVA irradiation and this induction was at least partly mediated by interleukin-6 (IL-6). We here provide evidence that UVA-induced IL-1 alpha and IL-1 beta play a central role in the induction of the synthesis both of IL-6 and collagenase/MMP-1. In contrast to the late increase of IL-1 alpha and IL-1 beta mRNA levels at 6 h postirradiation, bioactivity of IL-1 is already detectable at 1 h postirradiation. This early peak of IL-1 bioactivity appears to be responsible for the induction of IL-6 synthesis and together with IL-6 lead to an increase of the steady-state mRNA level of collagenase/MMP-1 as deduced from studies using IL-1 alpha and IL-1 beta antisense oligonucleotides or neutralizing antibodies against IL-1 alpha and IL-1 beta. Besides the early posttranslationally controlled release of intracellular IL-1, a latter pretranslationally controlled synthesis and release of IL-1 perpetuates the UV response. From these data we suggest a UV-induced cytokine network consisting of IL-1 alpha, IL-1 beta and IL-6, which via interrelated autocrine loops induce collagenase/MMP-1 and thus may contribute to the loss of interstitial collagen in cutaneous photoaging.

BACKGROUND: The effect of interleukin-2 (IL-2) in combination with antiretroviral therapy on HIV-1 replication and reservoirs was investigated. METHODS: In a prospective, open-label trial, 56 asymptomatic HIV-1-infected subjects (CD4 T cell count > 350 x 10(6) cells/l) were randomized to highly active antiretroviral therapy (HAART: stavudine, lamivudine, nelfinavir, saquinavir) with or without IL-2 (9 megaunits daily for 5 days in 6-weekly intervals for a total of eight cycles). Productive and latent infection were analysed in peripheral blood, and residual virus replication in the lymphoid tissue and in the cerebrospinal fluid. The influence of IL-2 on viral rebound after treatment discontinuation was studied. RESULTS: Virus replication was detected in 21 of 31 on-treatment lymph nodes despite undetectable plasma viraemia. Viral RNA was found in resting as well as in proliferating cells. RNA-negative patients tended towards more rapid proviral DNA elimination. Supplementary IL-2 led to a greater increase in CD4 T cell counts than HAART alone (P < 0.001), resulting in normalization in approximately 90% of IL-2-treated patients compared with approximately 50% HAART-only subjects. IL-2 had no beneficial effect on virus replication and on proviral DNA in peripheral blood. CONCLUSIONS: Viral persistence during HAART is partly a result of continued low-level replication, calling for more active regimens. IL-2 accelerates the normalization of CD4 T cell counts but does not impact on virus production or latency.

OBJECTIVE: Bedside monitoring of circulating blood volume has become possible with the introduction of an integrated fiberoptic monitoring system that calculates blood volume from the changes in blood concentration of indocyanine green dye 4 mins after injection. The aim of this investigation was to compare the blood volume estimate of the integrated fiberoptic monitoring system (group 1) with the standard methods of blood volume measurement using Evans blue (group 2), and indocyanine green measured photometrically (group 3). DESIGN: Prospective laboratory study. SETTING: Animal laboratory of a University's institute for experimental surgery. SUBJECTS: Eleven anesthetized, paralyzed, and mechanically ventilated piglets. INTERVENTIONS: A central venous catheter was used for the injection of the indicator dyes (Evans blue and indocyanine green). A fiberoptic thermistor catheter was advanced into the thoracic aorta. The fiberoptic catheter detects indocyanine green by reflection densitometry for the estimation of blood volume of the integrated fiberoptic monitoring system. Samples for the determination of Evans blue and indocyanine green concentrations were drawn from an arterial catheter in the femoral artery over a period of 17 mins after injection. MEASUREMENTS AND MAIN RESULTS: Measurements were performed during normovolemia, hypovolemia (blood withdrawal of < or = 30 mL/kg), and hypervolemia (retransfusion of the withdrawn blood plus an infusion of 10% hydroxyethyl starch [45 mL/kg]). Linear regression, correlation, and bias were calculated for the comparison of the blood volume estimates by the fiberoptic monitoring system (group 1) vs. the total blood volume estimates using Evans blue (group 2) and indocyanine green (group 3): group 1 = 0.82.group 2-26 mL; r2 = 82.71%; r = .91; n = 40; group 1-group 2 +/- 1 SD = -435 +/- 368 mL; group 1 = 0.79.group 3 + 50 mL; r2 = 74.81%; r = .87; n = 28; group 1-group 3 +/- 1 SD = -506 +/- 374 mL. CONCLUSIONS: The results demonstrate that the blood volume estimate of the fiberoptic monitoring system (group 1) correlates closely with the total blood volume measurement using Evans blue (group 2) and indocyanine green (group 3). Trapped indicator in the packed red cell column after centrifugation of the blood samples may account for an overestimation of group 2 and group 3 of approximately 10% to 14%, but there still remains a proportional difference of 10% between group 1 vs. group 2 and vs. group 3. This difference is due to the longer mixing times of group 3 (16 mins) and group 2 (17 mins), during which they are distributed in slowly exchanging blood pools. It seems that the blood volume estimate of the fiberoptic monitoring system (group 1) represents the actively circulating blood volume and may be useful for bedside monitoring.

BACKGROUND: The occurrence of phlebotomine sand flies in Central Europe was questioned until they were recorded for the first time in Germany in 1999, and ten years later also in Austria. The aim of this study was to investigate sand flies collected in Austria for their carrier status of Leishmania spp. FINDINGS: From 2012 to 2013 field studies were conducted in eastern Austria. Altogether, 22 individuals of sand flies were found, all morphologically identified as Phlebotomus (Transphlebotomus) mascittii Grassi, 1908. Twelve non-engorged female specimens with no visible remnants of a blood meal in their bodies were individually investigated for Leishmania spp. by ITS-1 real-time PCR. One out of these was positive for Leishmania, identified as Leishmania infantum by DNA sequencing. This finding suggests that L. infantum is not excreted by P. mascittii and possibly can establish an infection within P. mascittii. Interestingly, an asymptomatic dog living on the farm where this sand fly had been caught was also Leishmania-positive. CONCLUSIONS: This study provides new data on the suspected vector capacity of P. mascittii, being the northernmost sand fly species in Europe and in most central European regions the only sand fly species found. Proven vector capacity of P. mascittii for Leishmania spp. would be of significant medico-veterinary importance, not only with respect to expanding sand fly populations in Central Europe related to global warming, but also in the light of globalization and increasing movements of humans.

In military out of area missions of the Bundeswehr, it can be necessary to produce drinking water even from highly polluted surface waters containing a variety of organic, inorganic, and microbiological contaminants. Thus, mobile drinking water purification systems must be able to remove such contaminants as far as possible to meet the requirements of the German and European drinking water regulation/directive. Presently, two novel drinking water purification units applying membrane filtration undergo intensive long-term trials carried out by the Bundeswehr. If these trials positively proof the functionality of these units and their ability to remove all possible contaminants they shall substitute so far available devices which use large amounts of chemicals and charcoal filtration for water purification.In the course of a research project, the functionality of the new devices and their efficacy to remove high amounts of algae, microbes, and organic and inorganic pollutants are additionally tested in “worst-case” field studies. In September 2000, the first mobile drinking water purification unit was tested at the Teltowkanal in Berlin, Germany.This canal was chosen because it carries high burdens of municipal sewage effluents. The results from the fatigue test confirmed the ability of the water purification unit to reduce the concentrations of all contaminants meeting the maximum tolerance levels set by the German/European drinking water regulation.The pre-filtration device was very effective in removing algae and solid particles to protect the membranes from clogging and to enable an almost maintenance-free operation. Residues of pharmaceuticals and some other organic contaminants have almost totally been removed from the surface water where they were detected at individual concentrations up to the μg/L-level. Gewinnung von Trinkwasser aus hochbelasteten Oberflächengewässern: Entfernung organischer, anorganischer und mikrobieller Kontaminanten mittels mobiler Membranfiltrationsanlagen Im Rahmen militärischer Auslandseinsätze der Bundeswehr kann es notwendig sein, Trinkwasser auch aus hochkontaminierten Oberflächengewässern zu gewinnen, die eine Vielzahl verschiedener organischer, anorganischer und mikrobiologischer Verunreinigungen enthalten. Mobile Trinkwasseraufbereitungsanlagen müssen deshalb in der Lage sein, auch solche Kontaminanten soweit wie möglich zu entfernen, um die Anforderungen der deutschen bzw. europäischen Trinkwasserverordnung/-richtlinie zu erfüllen. Derzeit werden mehrere neuartige, auf der Membranfiltrationstechnik basierende Trinkwasseraufbereitungsanlagen im Rahmen extensiver Langzeittests bei der Bundeswehr untersucht. Sollten diese Tests im Hinblick auf die Funktionalität der Anlage und ihrer Fähigkeit zur Entfernung aller relevanten Kontaminanten positiv verlaufen, so sollen diese die bislang verfügbaren Anlagen ersetzen, die große Mengen an Chemikalien und Aktivkohle verbrauchen. Im Rahmen eines Forschungsprojekts wird die Funktionalität und die Effektivität zweier mobiler Trinkwasseranlagen zur Entfernung großer Mengen Algen, Mikroorganismen, organischer und anorganischer Verunreinigungen in sogenannten „Worst-case”︁-Szenarios getestet. Im September 2000 wurde die erste der beiden mobilen Trinkwasseraufbereitungsanlagen am Teltowkanal in Berlin getestet, der aufgrund seiner hohen Belastung durch kommunale Abwässer ausgewählt wurde. Die Ergebnisse dieses Versuchs zeigten, dass die Anlage die Konzentrationen aller geprüften Parameter deutlich unterhalb der gesetzlich geforderten Trinkwassergrenzwerte reduzieren konnte. Die Vorfiltration mittels konventioneller Beutelfilter war in der Lage, Algen und Feststoffpartikel effektiv zu entfernen und die Membranen vor Verblockung zu schützen und somit einen weitgehend wartungsfreien Betrieb zu ermöglichen. Rückstände von Arzneimitteln und anderer organischer Kontaminanten, die z. T. in individuellen Konzentrationen bis in den μg/L-Bereich im Teltowkanal gefunden wurden, konnten mit der Anlage fast vollständig (i. d. R. < NWG) entfernt werden.

Diabetes mellitus (DM) is associated with a state of chronic hyperglycemia with a highly increased risk of vascular complications. The current study aimed to investigate microcirculation abnormalities in patients with type 2 DM and those with pre-DM using nailfold videocapillaroscopy (NVC) and evaluate the possible correlation with microvascular complications.A total of 115 patients with type 2 DM, 41 patients with pre-DM, and 37 healthy subjects without diabetes were enrolled. All subjects underwent NVC to evaluate capillary density, length, morphology, distribution, presence of enlarged loops or hemorrhages, and blood flow. NVC score was used to quantitate the aforementioned characteristics.Patients with type 2 DM showed significantly increased alterations including reduced capillary length (29.6%), irregular distribution (35.7%), and abnormal morphology (59.1%), while the corresponding NVC scores were comparable to those of control subjects. In addition, subjects with pre-DM had a significantly higher NVC score and greater alterations in distribution (26.8%) and morphology (48.8%) than control subjects. NVC score was positively correlated with diabetic peripheral neuropathy (DPN) and the number of microvascular complications.NVC identified a high frequency of microcirculation abnormalities in subjects with pre-DM or type 2 DM compared to those in the control group. NVC score was also capable of detecting microvascular complications in patients with type 2 DM and was correlated with DPN and the number of microvascular complications.

The existing threat by criminal (intentional) use of electromagnetic tools is investigated. Reported Intentional Electromagnetic Interference (IEMI) attacks and similar incidents will be analyzed and discussed in regard to aspects like motivation and technical skills of the culprits, characteristics of the generated IEMI environment as well as effects on the target systems. Concluding common characteristics will lead to a discussion of the technological challenge of recognition and identification of an IEMI attack as well as backtracking of observed malfunction and destructions to an external IEMI environment.

A high vaccination rate of older and particularly chronically ill people against coronavirus disease-2019 (COVID-19) is likely one of the most important factors in containing the pandemic. When Germany's vaccination campaign started on December 2020, vaccination prioritization was initially carried out starting with older population groups. Side effect rates in 1065 individuals who had received the first dose of the messenger ribonucleic acid (mRNA) vaccine BNT162b2 Tozinameran from BioNTech/Pfizer three weeks earlier were examined retrospectively. An age- and gender-graded data analysis showed clear age and gender differences with regard to vaccine-related adverse effects. In 77% of all individuals over 80 years of age, no local or systemic side effects were reported after the first vaccination, whereas in the age group up to 80 years, only 37% showed no side effects. In the whole study population, 64% of females and 73% of males reported no adverse effects. The initial vaccination with mRNA vaccine BNT162b2 shows an overall low profile of side effects. Particularly in those over 80 years, an extraordinarily good tolerance with equally good effectiveness is evident. The sex comparison showed that women suffer more often from adverse vaccination reactions. In order to achieve sufficient herd immunity, both age- and gender-dependent vaccination reactions and any difference in the maintenance of immunity should be considered in future vaccination strategies.

This study aimed to compare the diagnostic performance of [18F]PSMA-1007 positron emission tomography/computed tomography (PET/CT) (18F-PSMA) and [68Ga]Ga-PSMA-11 PET/CT (68Ga-PSMA) by identifying prostate-specific antigen (PSA) threshold levels for optimal detecting recurrent prostate cancer (PC) and to compare both methods. Retrospectively, the study included 264 patients. The performances of 18F-PSMA and 68Ga-PSMA in relation to the pre-scan PSA were assessed by receiver operating characteristic (ROC) curve. 18F-PSMA showed PC-lesions in 87.5% (112/128 patients), while 68Ga-PSMA identified them in 88.9% (121/136). For 18F-PSMA biochemical recurrent (BCR) patients treated with radical prostatectomy (78/128, patient group: F-RP), a PSA of 1.08 ng/mL was found to be the optimal cut-off level for predicting positive and negative scans (AUC = 0.821; 95%, CI: 0.710−0.932), while for prostatectomized 68Ga-PSMA BCR-patients (89/136, patient group: Ga-RP), the cut-off was 1.84 ng/mL (AUC = 0.588; 95%, CI: 0.410−0.766). In patients with PSA < 1.08 ng/mL (F-RP) 76.3% and <1.84 ng/mL (Ga-RP) 78.6% scans were positive, whereas patients with PSA ≥ 1.08 ng/mL (F-RP) or 1.84 ng/mL (Ga-RP) had positive scan results in 100% and 91.5% (p < 0.001/p = 0.085). The identified PSA thresholds for PSMA-mappable PC lesions in BCR-patients (RP) showed a better separation for 18F-PSMA with regard to the distinguishing of positive and negative PC-lesions compared to 68Ga-PSMA. However, the two PSMA PET/CT tracers gave similar overall findings.

Routine [68Ga]Ga-PSMA-11 PET/CT (one hour post-injection) has been shown to accurately detect prostate cancer (PCa) lesions. The goal of this study is to evaluate the benefit of a dual-time point imaging modality for the staging and restaging of PCa patients. Biphasic [68Ga]Ga-PSMA-11 PET/CT of 233 patients, who underwent early and late scans (one/three hours post-injection), were retrospectively studied. Tumor uptake and biphasic lesion detection for 215 biochemically recurrent patients previously treated for localized PCa (prostatectomized patients (P-P)/irradiated patients (P-I) and 18 patients suspected of having primary PCa (P-T) were separately evaluated. Late [68Ga]Ga-PSMA-11 PET/CT imaging detected 554 PCa lesions in 114 P-P patients, 187 PCa lesions in 33 P-I patients, and 47 PCa lesions in 13 P-T patients. Most patients (106+32 P-P/P-I, 13 P-T) showed no additional PCa lesions. However, 11 PSMA-avid lesions were only detected in delayed images, and 33 lesions were confirmed as malignant by a SUVmax increase. The mean SUVmax of pelvic lymph node metastases was 25% higher (p &lt; 0.001) comparing early and late PET/CT. High positivity rates from routine [68Ga]Ga-PSMA-11 PET/CT for the staging and restaging of PCa patients were demonstrated. There was no decisive influence of additional late imaging with PCa lesion detection on therapeutic decisions. However, in a few individual cases, additional delayed scans provided an information advantage in PCa lesion detection due to higher tracer uptake and improved contrast.

Epidemic conjunctivitis can be associated with viral or bacterial pathogens, whereas epidemic keratoconjunctivitis is caused mainly by adenoviruses type 8,19 and 37. In Germany, the incidence of adenovirus conjunctivitis cases increased from 0.2 per 100,000 inhabitants (in 2001 and 2002) eventually to 0.5 in 2003 and 0.8 in 2004. The detection of adenovirus in conjunctival swabs is notifiable to the local health departments. Data about cases with positive conjunctival swabs are then transmitted to the Robert Koch-Institut. Quality control of data takes place and national surveillance data of confirmed cases with adenovirus conjunctivitis are published. From January to April 2004 the national surveillance system captured an outbreak with 1024 cases (131 laboratory confirmed). Analysis of the national surveillance data showed that in March 2004 the group primarily affected by epidemic keratoconjunctivitis was young men between 18-29 years old followed by an increased number of notifications from women in the same age group. Meanwhile the German Armed Forces experienced an outbreak of conjunctivitis, almost exclusively without laboratory confirmation, affecting 6378 soldiers. Despite the small number of laboratory confirmed cases it became clear from the analysis of the national surveillance data that person-to-person transmission between young men and similar age groups of the population did occur. Whether the outbreak started within the garrisons of the German Armed Forces or whether it was triggered within these accommodations, there is clearly a need for the national and the military public health institutions to work together on guidelines to handle future challenges.

Abstract In the presented work two experimental pyrolants for use in blackbody infrared decoy flares showing higher performance than baseline magnesium/polytetrafluoroethylene/Viton® ( MTV ) were investigated. These pyrolants are based on fuels hitherto unknown to pyrotechnics: magnesium diboride, MgB 2 , and dimagnesium silicide, Mg 2 Si. Both fuels were formulated with polytetrafluoroethylene, PTFE and a fluorocarbon binder Viton® (designated MbTV and MsTV ). MsTV yields higher radiance, L λ (W cm −2 sr −1 ) in the mid infrared range (2–5 μm) than MTV at same stoichiometry. The volumetric spectral efficiency E λ (J cm −3 sr −1 ) of MbTV is also superior to MTV. MbTV thus allows for size reduction of black body countermeasure flares and thereby has potential to enhance the survivability of aircraft in hostile environments. Due to its very high burning rate MsTV qualifies for first fire and igniter applications.

A 37-year-old man developed an ipsilateral headache which fulfilled the criteria for cluster headache after orbital extenteration because of a traumatic lesion of the bulb. The headache could be treated successfully by drugs usually applied in the therapy of cluster headache. Six similar cases of cluster headache after orbital exenteration could be identified in the literature suggesting that the eye itself is not necessarily part of the pathogenesis of cluster headache. We hypothesize that orbital exenteration can cause cluster headache by lesions of sympathetic structures. Possibly, these mechanisms are similar to those of sympathetic reflex dystrophy (Sudeck-Leriche syndrome) causing pain of the limbs.

Temperature cycling at metal–oxide–semiconductor (MOS) sensor elements in combination with pattern recognition algorithms is applied for detecting various gas mixtures. Through this process, the influence concerning the capability of gas identification has been investigated in the case of transferring the recorded reference library from a distinct sensor element to several further sensors. This comparative study has been followed based on responses of four sensors exposed to the same gas composition. The results are analyzed and compared for two sensor types with differing variations of sensing-layer resistance. It is shown that gas identification, particularly the determination of gas concentration, is improved by the implementation of sensors with smaller resistance variations if the reference library from one sensor is also used for other sensor elements.

68Ga-PSMA-11 positron-emission tomography/computed tomography (PET/CT) is commonly used for restaging recurrent prostate cancer (PC) in European clinical practice. The goal of this study is to determine the optimum time for performing these PET/CT scans in a large cohort of patients by identifying the prostate-specific-antigen (PSA) and PSA kinetics thresholds for detecting and localizing recurrent PC. This retrospective analysis includes 581 patients with biochemical recurrence (BC) by definition. The performance of 68Ga-PSMA-11 PET/CT in relation to the PSA value at the scan time as well as PSA kinetics was assessed by the receiver-operating-characteristic-curve (ROC) generated by plotting sensitivity versus 1-specificity. Malignant prostatic lesions were identified in 77%. For patients that were treated with radical prostatectomy (RP) a PSA value of 1.24 ng/mL was found to be the optimal cutoff level for predicting positive and negative scans, while for patients previously treated with radiotherapy (RT) it was 5.75 ng/mL. In RP-patients with PSA value &lt;1.24 ng/mL, 52% scans were positive, whereas patients with PSA ≥1.24 ng/mL had positive scan results in 87%. RT-patients with PSA &lt;5.75 ng/mL had positive scans in 86% and for those with PSA ≥5.75 ng/mL 94% had positive scans. This study identifies the PSA and PSA kinetics threshold levels for the presence of 68Ga-PSMA-11 PET/CT-detectable PC-lesions in BC patients.

This paper looks into the mechanical and electromagnetic design for rotors with embedded magnets of permanent-magnet-synchronous machines. In a study it has been investigated in which way a solid bridge between the permanent magnets improves the mechanical stability of the system and if it has an influence on the electromagnetic performance. In the second part a new design process for the rotor is introduced. The aim of this design process is to decouple the calculation of the reluctance torque from the permanent magnet torque and to reduce the complexity of the electromagnetic design for the rotor.

Background: Hybrid imaging with prostate-specific membrane antigen (PSMA) is gaining importance as an increasingly meaningful tool for prostate cancer (PC) diagnostics and as a guide for therapy decisions. This study aims to investigate and compare the performance of [18F]PSMA-1007 (18F-PSMA) and [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography (68Ga-PSMA) in the initial staging of PC patients. Methods: The data of 88 biopsy-proven patients were retrospectively evaluated. PSMA-avid lesions were compared with the histopathologic Gleason Score (GS) for prostate biopsies, and the results were plotted by receiver operating characteristic (ROC)-curve. Optimal maximum standardized uptake value (SUVmax) cut-off values were rated using the Youden index. Results: 18F-PSMA was able to distinguish GS ≤ 7a from ≥7b with a sensitivity of 62%, specificity of 85%, positive predictive value (PPV) of 92%, and accuracy of 67% for a SUVmax of 8.95, whereas sensitivity was 54%, specificity 91%, PPV 93%, and accuracy 66% for 68Ga-PSMA (SUVmax 8.7). Conclusions: Both methods demonstrated a high concordance of detected PSMA-avid lesions with histopathologically proven PC. 18F-PSMA and 68Ga-PSMA are both suitable for the characterization of primary PC with a comparable correlation of PSMA-avid lesions with GS. Neither method showed a superior advantage. Our calculated SUVmax thresholds may represent valuable parameters in clinical use to distinguish clinically significant PC (csPC) from non-csPC.

// Manuela A. Hoffmann 1 , 2 , 3 , Hans-Georg Buchholz 2 , Helmut J. Wieler 3 , Thomas H&#x00F6;fner 4 , Jonas M&#x00FC;ller-H&#x00FC;benthal 5 , Ludwin Trampert 6 and Mathias Schreckenberger 2 1 Department of Occupational Health and Safety, Supervisory Center for Radiation Protection, Federal Ministry of Defense, Bonn 53123, Germany 2 Clinic of Nuclear Medicine, Johannes Gutenberg-University, Mainz 55101, Germany 3 Clinic of Nuclear Medicine, Bundeswehr Central Hospital, Koblenz 56072, Germany 4 Clinic of Urology, Johannes Gutenberg-University, Mainz 55101, Germany 5 Practice of Radiology and Nuclear Medicine, Praxis im K&#x00F6;lnTriangle, K&#x00F6;ln 50679, Germany 6 Clinic of Nuclear Medicine, Klinikum Mutterhaus der Borrom&#x00E4;erinnen, Trier 54290, Germany Correspondence to: Manuela A. Hoffmann, email: manuhoffmann@web.de Keywords: positivity rate; 68Gallium-PSMA PET/CT; prostate-specific antigen; prostate cancer; biochemical recurrence Received: July 04, 2019&emsp;&emsp;&emsp;&emsp; Accepted: September 10, 2019&emsp;&emsp;&emsp;&emsp; Published: October 22, 2019 ABSTRACT Background: The aim of the present study is to analyze the efficacy of 68Gallium (Ga)-PSMA-11 PET/CT for detecting and localizing recurrent prostate carcinoma (PC) in patients with different prostate-specific antigen (PSA), PSA velocity (PSAvel) and doubling time (PSAdt). Results: The PR of 68Ga-PSMA-11 PET/CT showed a positive relationship with PSA levels. Even at restaging PSA-values (PSAV) of lower than 0.2 ng/ml, PR was 41%. For PSAV of 0.2-&lt;0.5 ng/ml the PR was 45%, 62% for PSAV of 0.5-&lt;1.0 and 72% for PSAV of 1.0-&lt;2.0 ng/ml. The PR increased to 85% for PSAV of 2.0-&lt;5.0 and reached 94% at PSAV of &#x2265;5.0 ng/ml. At PSA of &lt;1 ng/ml/y the PR of PSAvel was 50% and increased to 98% at PSA &gt;5 ng/ml/y. No significant association was found for PSAdt. Methods: PET/CT scans of 660 patients with biochemical recurrence (BCR) after primary therapy of PC were included in the analysis. We correlated serum PSA levels, measured at the time of imaging with PSMA PET/CT-positivity rates (PR) as well as PSAvel (in 225 patients) and PSAdt (660 patients). Additionally we compared the incidence of localized disease to metastases as related to these PSA-biomarkers. Conclusion: We have shown, in a large cohort of patients, that 68Ga-PSMA-11 PET/CT is a sensitive tool for restaging PC and has a high detection efficacy, even in patients with very low PSA levels (&lt;0.2 ng/ml). Thus 68Ga-PSMA-11 PET/CT both identify and localize recurrent disease with implications for a more direct treatment approach (localized vs. systemic therapy).

We have developed a multichannel software defined radio-based transceiver measurement system for use in general microwave tomographic applications. The unit is compact enough to fit conveniently underneath the current illumination tank of the Dartmouth microwave breast imaging system. The system includes 16 channels that can both transmit and receive and it operates from 500 MHz to 2.5 GHz while measuring signals down to -140 dBm. As is the case with multichannel systems, cross-channel leakage is an important specification and must be lower than the noise floors for each receiver. This design exploits the isolation inherent when the individual receivers for each channel are physically separate; however, these challenging specifications require more involved signal isolation techniques at both the system design level and the individual, shielded component level. We describe the isolation design techniques for the critical system elements and demonstrate specification compliance at both the component and system level.